Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy D Lin

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Vaccine|February 6, 2020
The risk of febrile seizures following influenza and 13-valent pneumococcal conjugate vaccinesMeghan A Baker, Christopher Jankosky, W Katherine Yih, et al.
Pharmacoepidemiology and Drug Safety|January 11, 2018
Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel SystemElizabeth A Chrischilles, Joshua J Gagne, Bruce Fireman, et al.
JAMA Network Open|May 31, 2022
Effect of Mailing Educational Material to Patients With Atrial Fibrillation and Their Clinicians on Use of Oral Anticoagulants: A Randomized Clinical TrialSean D Pokorney, Noelle Cocoros, Hussein R Al-Khalidi, et al.
Plos One|February 3, 2023
Real-world performance of SARS-Cov-2 serology tests in the United States, 2020Carla V Rodriguez-Watson, Anthony M Louder, Carly Kabelac, et al.
Plos One|February 10, 2023
Real-world utilization of SARS-CoV-2 serological testing in RNA positive patients across the United StatesCarla V Rodriguez-Watson, Natalie E Sheils, Anthony M Louder, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Vaccine|February 6, 2020
The risk of febrile seizures following influenza and 13-valent pneumococcal conjugate vaccinesMeghan A Baker, Christopher Jankosky, W Katherine Yih, et al.
Pharmacoepidemiology and Drug Safety|January 11, 2018
Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel SystemElizabeth A Chrischilles, Joshua J Gagne, Bruce Fireman, et al.
JAMA Network Open|May 31, 2022
Effect of Mailing Educational Material to Patients With Atrial Fibrillation and Their Clinicians on Use of Oral Anticoagulants: A Randomized Clinical TrialSean D Pokorney, Noelle Cocoros, Hussein R Al-Khalidi, et al.
Plos One|February 3, 2023
Real-world performance of SARS-Cov-2 serology tests in the United States, 2020Carla V Rodriguez-Watson, Anthony M Louder, Carly Kabelac, et al.
Plos One|February 10, 2023
Real-world utilization of SARS-CoV-2 serological testing in RNA positive patients across the United StatesCarla V Rodriguez-Watson, Natalie E Sheils, Anthony M Louder, et al.
Pageof 3